Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Cash Acquisitions

Amneal Pharmaceuticals Inc Cash Acquisitions Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Cash Acquisitions from 2018 to 2018.
  • Amneal Pharmaceuticals Inc Cash Acquisitions for the quarter ending September 09, 2018 was $-3m
  • Amneal Pharmaceuticals Inc Cash Acquisitions for the last 12 months ending December 12, 2018 was $-325m a 95.56% decrease of -310m year over year
  • Amneal Pharmaceuticals Inc Annual Cash Acquisitions for 2018 was $-325m a 95.56% decrease of -310m from 2017
  • Amneal Pharmaceuticals Inc Annual Cash Acquisitions for 2015 was $-14m a -169.02% increase of 24m from 2014
  • Amneal Pharmaceuticals Inc Annual Cash Acquisitions for 2014 was $-39m
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Cash Acquisitions Data

09/2018$-3m
06/2018$-321m

Annual AMRX Cash Acquisitions Data

2018$-325m
2015$-14m
2014$-39m